MDxHealth SA Stock Euronext Bruxelles
Equities
MDXH
BE0974461940
Biotechnology & Medical Research
Sales 2023 | 64.39M 68.84M | Sales 2024 * | 73.53M 78.62M | Capitalization | 63.14M 67.51M |
---|---|---|---|---|---|
Net income 2023 | -39M -41.7M | Net income 2024 * | -26M -27.8M | EV / Sales 2023 | 1.51 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.86 x |
P/E ratio 2023 |
-2.37
x | P/E ratio 2024 * |
-2.46
x | Employees | 255 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 97.37% |
Latest transcript on MDxHealth SA
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |